It has been around a year since Beam Therapeutics slashed its headcount and R&D programmes to focus mainly on a sickle cell disease candidate – and the biotech has now revealed the first data with the ...
Armed with new proof-of-concept data showing that its in vivo base-editing therapy BEAM-302 can correct the gene mutation in alpha-1 antitrypsin deficiency (AATD), Beam Therapeutics is seeking to ...
Abstract: Base station (BS) sleeping is an effective way to reduce the energy consumption of mobile networks. Previous efforts to design sleeping control algorithms mainly rely on stochastic traffic ...
OpenAI has announced it is expanding its UK footprint with its first permanent office, based in London - following halt of the Stargate project Days after OpenAI paused its Stargate UK data centre ...
Abstract: Efficient acceleration of Deep Neural Networks is a manifold task. In order to save memory requirements and reduce energy consumption we propose the use of dedicated accelerators with novel ...
Customer stories Events & webinars Ebooks & reports Business insights GitHub Skills ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results